SARS-CoV-2 infection in multiple sclerosis patients: interaction with treatments, adjuvant therapies, and vaccines against COVID-19
Author:
Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),Neurology
Link
https://link.springer.com/content/pdf/10.1007/s00415-022-11237-1.pdf
Reference217 articles.
1. Palao M, Fernández-Díaz E, Gracia-Gil J et al (2020) Multiple sclerosis following SARS-CoV-2 infection. Mult Scler Relat Disord. https://doi.org/10.1016/j.msard.2020.102377
2. World Health Organization Coronavirus Disease (COVID-19) Situation Reports. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/. Accessed 26 May 2022
3. Reyes S, Cunningham A, Kalincik T et al (2021) Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: an international consensus statement. J Neuroimmunol 357:577627. https://doi.org/10.1016/J.JNEUROIM.2021.577627
4. Berlin DA, Gulick RM, Martinez FJ (2020) Severe Covid-19. N Engl J Med 383:2451–2460. https://doi.org/10.1056/NEJMCP2009575
5. Dos Santos W (2021) Impact of virus genetic variability and host immunity for the success of COVID-19 vaccines. Biomed Pharmacother 136:111272. https://doi.org/10.1016/J.BIOPHA.2021.111272
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparing the consequences of COVID-19 vaccination between central nervous system (CNS) demyelinating diseases and other neurological disorders;Vaccine;2024-10
2. Single‐cell multi‐omics analysis of COVID‐19 patients with pre‐existing autoimmune diseases shows aberrant immune responses to infection;European Journal of Immunology;2023-10-20
3. Safety and effectiveness of the booster dose of mRNA COVID-19 vaccines in people with multiple sclerosis: A monocentric experience;Multiple Sclerosis and Related Disorders;2023-04
4. Summary of Safety and Efficacy of COVID Vaccination in Patients with Multiple Sclerosis;European Neurology;2023
5. SARS-CoV-2, long COVID, prion disease and neurodegeneration;Frontiers in Neuroscience;2022-09-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3